| Name |
Rispolept Consta 25 mg prašak i otapalo za suspenziju za injekciju s produljenim oslobađanjem |
| Marketing Authorisation Number |
HR-H-137353036 |
| Active Substance |
risperidon |
| Composition |
jedna bočica (=65,6 mg mikrosfere) sadrži 25 mg risperidon |
| Pharmaceutical Form |
prašak i otapalo za suspenziju za injekciju s produljenim oslobađanjem |
| Manufacturer |
Janssen Pharmaceutica N.V., Beerse, Belgija |
| Marketing Authorisation Holder |
Johnson & Johnson S.E. d.o.o., Oreškovićeva 6h, Zagreb, Hrvatska |
| Marketing Authorisation Date |
30.09.2020 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/19-02/41 |
| Registration Number |
381-12-01/30-20-08 |
| Prescription |
na recept |
| Type of prescription |
ograničeni recept
|
| Distribution |
u ljekarni |
| Advertising to general public |
zabranjeno |
| ATC Code |
N05AX08 |
| Medicinal product marketed in the Croatia |
Da |
| SmPC |
download |
| PL |
download |
